{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:19:14Z","timestamp":1792793954339,"version":"4.5.0"},"reference-count":392,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004733","name":"Universidade de Macau","doi-asserted-by":"publisher","award":["MYRG-2024-00162-FHS"],"award-info":[{"award-number":["MYRG-2024-00162-FHS"]}],"id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004733","name":"Universidade de Macau","doi-asserted-by":"publisher","award":["MYRG-GRG2025-00095-FHS"],"award-info":[{"award-number":["MYRG-GRG2025-00095-FHS"]}],"id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2025A1515012894"],"award-info":[{"award-number":["2025A1515012894"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0005\/2024\/AKP"],"award-info":[{"award-number":["0005\/2024\/AKP"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0047\/2023\/RIB2"],"award-info":[{"award-number":["0047\/2023\/RIB2"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Colloid and Interface Science"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cis.2026.104054","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:57:07Z","timestamp":1790006227000},"page":"104054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Decoding the uptake pathway of nanoparticles in tumor cells: mechanisms, developments and challenges"],"prefix":"10.1016","volume":"358","author":[{"given":"Zihan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cis.2026.104054_bb0005","series-title":"Principles of Tumors","first-page":"33","article-title":"Chapter 2 - Theories and definitions of tumors","author":"Bignold","year":"2015"},{"key":"10.1016\/j.cis.2026.104054_bb0010","author":"WHO"},{"key":"10.1016\/j.cis.2026.104054_bb0015","series-title":"Principles of Tumors","first-page":"357","article-title":"Chapter 14 - Aspects of the prevention of tumors","author":"Bignold","year":"2015"},{"key":"10.1016\/j.cis.2026.104054_bb0020","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes Dis"},{"key":"10.1016\/j.cis.2026.104054_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112503","article-title":"Clinical implications of chemotherapeutic agent organ toxicity on perioperative care","volume":"146","author":"Zeien","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cis.2026.104054_bb0030","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ejca.2006.10.015","article-title":"Pharmacokinetics in cancer chemotherapy","volume":"43","author":"Garattini","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cis.2026.104054_bb0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cis.2026.104054_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/bmm2.12079","article-title":"Regulated cell death-amplified sonodynamic anti-tumor immune nanotherapeutics","volume":"2","author":"Zhou","year":"2024","journal-title":"BMEMat"},{"key":"10.1016\/j.cis.2026.104054_bb0045","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jconrel.2022.03.043","article-title":"Strategies to improve the EPR effect: a mechanistic perspective and clinical translation","volume":"345","author":"Ikeda-Imafuku","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113790","article-title":"Formulation of siRNA nanoparticles, transfection and enhanced adhesion -penetration in nasal mucosal tissue","volume":"383","author":"Sanchez-Castillo","year":"2025","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb0055","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41596-021-00665-4","article-title":"Synthesis of siRNA nanoparticles to silence plaque-destabilizing gene in atherosclerotic lesional macrophages","volume":"17","author":"Huang","year":"2022","journal-title":"Nat Protoc"},{"key":"10.1016\/j.cis.2026.104054_bb0060","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.1021\/acsnano.8b03900","article-title":"Quantifying the ligand-coated nanoparticle delivery to cancer cells in solid tumors","volume":"12","author":"Dai","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2026.104054_bb0065","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C6CS00636A","article-title":"Cellular uptake of nanoparticles: journey inside the cell","volume":"46","author":"Behzadi","year":"2017","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.cis.2026.104054_bb0070","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.3390\/ijms12053303","article-title":"Nanomedicine: application areas and development prospects","volume":"12","author":"Boulaiz","year":"2011","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0075","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","article-title":"Nanomedicine in cancer therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.cis.2026.104054_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adx1576","article-title":"The evolution of nanomedicine: the rise of next-generation nanomaterials in cancer nanomedicine","volume":"11","author":"Forgham","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.cis.2026.104054_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/bmm2.12083","article-title":"Rational design of a nonclassical liposomal nanoscale drug delivery system for innovative cancer therapy","volume":"2","author":"Wang","year":"2024","journal-title":"BMEMat"},{"key":"10.1016\/j.cis.2026.104054_bb0090","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1021\/acsptsci.5c00241","article-title":"Advancing cancer-targeted nanotherapies with tumor homing peptides","volume":"8","author":"Rocchi","year":"2025","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.cis.2026.104054_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75253-9","article-title":"Investigating the optimum size of nanoparticles for their delivery into the brain assisted by focused ultrasound-induced blood\u2013brain barrier opening","volume":"10","author":"Ohta","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.cis.2026.104054_bb0105","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2022.08.003","article-title":"Pulmonary delivery of size-transformable nanoparticles improves tumor accumulation and penetration for chemo-sonodynamic combination therapy","volume":"350","author":"Ma","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114759","article-title":"Liposomal particokinetics and intratumoral microdistribution: a quantitative reassessment of the enhanced permeability and retention effect","volume":"393","author":"Cai","year":"2026","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb0115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nantod.2014.04.008","article-title":"Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects","volume":"9","author":"Barua","year":"2014","journal-title":"Nano Today"},{"key":"10.1016\/j.cis.2026.104054_bb0120","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.3390\/cancers14122904","article-title":"Nanomedicine penetration to tumor: challenges, and advanced strategies to tackle this issue","volume":"14","author":"Munir","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.cis.2026.104054_bb0125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2319880121","article-title":"Curvature-mediated rapid extravasation and penetration of nanoparticles against interstitial fluid pressure for improved drug delivery","volume":"121","author":"Jiang","year":"2024","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0130","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.7150\/thno.39995","article-title":"Towards extracellular matrix normalization for improved treatment of solid tumors","volume":"10","author":"Abyaneh","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.cis.2026.104054_bb0135","article-title":"Tumor extracellular matrix modulating strategies for enhanced antitumor therapy of nanomedicines","volume":"16","author":"Li","year":"2022","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.cis.2026.104054_bb0140","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1021\/acs.molpharmaceut.1c00455","article-title":"Tumor-associated fibroblast-targeting nanoparticles for enhancing solid tumor therapy: progress and challenges","volume":"18","author":"Li","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.cis.2026.104054_bb0145","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.2147\/IJN.S279192","article-title":"Nanomedicine strategies to enhance tumor drug penetration in pancreatic cancer","volume":"16","author":"Lu","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2026.104054_bb0150","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1039\/D5NR04462F","article-title":"Factors governing tumor penetration of nanomedicines: intrinsic and extrinsic determinants","volume":"18","author":"Shin","year":"2026","journal-title":"Nanoscale"},{"key":"10.1016\/j.cis.2026.104054_bb0155","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1021\/acs.molpharmaceut.5c00474","article-title":"Drug delivery systems for overcoming physical barriers in cancer therapy","volume":"22","author":"Yi","year":"2025","journal-title":"Mol Pharm"},{"key":"10.1016\/j.cis.2026.104054_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216166","article-title":"Barrier permeation and improved nanomedicine delivery in tumor microenvironments","volume":"562","author":"Liu","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cis.2026.104054_bb0165","doi-asserted-by":"crossref","first-page":"9243","DOI":"10.1021\/acsnano.6b02776","article-title":"The binding site barrier elicited by tumor-associated fibroblasts interferes disposition of nanoparticles in stroma-vessel type tumors","volume":"10","author":"Miao","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2026.104054_bb0170","doi-asserted-by":"crossref","DOI":"10.1593\/tlo.13409","article-title":"The effect of molecular weight, PK, and valency on tumor biodistribution and efficacy of antibody-based drugs","volume":"6","author":"Muchekehu","year":"2013","journal-title":"Transl Oncol"},{"key":"10.1016\/j.cis.2026.104054_bb0175","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1158\/0008-5472.CAN-20-3822","article-title":"Transient competitive inhibition bypasses the binding site barrier to improve tumor penetration of trastuzumab and enhance T-DM1 efficacy","volume":"81","author":"Bordeau","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.cis.2026.104054_bb0180","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.cis.2026.104054_bb0185","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.3390\/app15063189","article-title":"Enhancement of EPR effect for passive tumor targeting: current status and future perspectives","volume":"15","author":"Vagena","year":"2025","journal-title":"Appl Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0190","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/jpm11080771","article-title":"The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application","volume":"11","author":"Wu","year":"2021","journal-title":"J Person Med"},{"key":"10.1016\/j.cis.2026.104054_bb0195","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","article-title":"Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer?","volume":"27","author":"Nakamura","year":"2016","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.cis.2026.104054_bb0200","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1158\/0008-5472.CAN-12-4561","article-title":"Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology","volume":"73","author":"Prabhakar","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.cis.2026.104054_bb0205","first-page":"445","article-title":"Enhancing drug penetration in solid tumors via nanomedicine: evaluation models, strategies and perspectives","volume":"32","author":"Shen","year":"2024","journal-title":"Bioact Mater"},{"key":"10.1016\/j.cis.2026.104054_bb0210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","article-title":"Tumor targeting via EPR: Strategies to enhance patient responses","volume":"130","author":"Golombek","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2026.104054_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2025.214636","article-title":"Enhanced permeability and retention (EPR) effect: advances in nanomedicine for improved tumor targeting","volume":"181","author":"Khan","year":"2026","journal-title":"Biomater Adv"},{"key":"10.1016\/j.cis.2026.104054_bb0220","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/annonc\/mdh097","article-title":"Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl (CAELYX\/Doxil) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer","volume":"15","author":"O\u2019Brien","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cis.2026.104054_bb0225","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1200\/JCO.2011.39.5848","article-title":"Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non\u2013small-cell lung cancer: final results of a phase iii trial","volume":"30","author":"Socinski","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cis.2026.104054_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115760","article-title":"Emerging nanoparticle-based therapies for pancreatic cancer: current clinical landscape","volume":"229","author":"Salgado-Pascual","year":"2026","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2026.104054_bb0235","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1111\/cas.13630","article-title":"Stromal barriers to nanomedicine penetration in the pancreatic tumor microenvironment","volume":"109","author":"Tanaka","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0240","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/jpm13030389","article-title":"Approaches to improve EPR-based drug delivery for cancer therapy and diagnosis","volume":"13","author":"Subhan","year":"2023","journal-title":"J Person Med"},{"key":"10.1016\/j.cis.2026.104054_bb0245","doi-asserted-by":"crossref","first-page":"8101","DOI":"10.2147\/IJN.S153053","article-title":"Bypassing the EPR effect with a nanomedicine harboring a sustained-release function allows better tumor control","volume":"12","author":"Shen","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2026.104054_bb0250","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/s41467-025-56768-z","article-title":"A multistage drug delivery approach for colorectal primary tumors and lymph node metastases","volume":"16","author":"Yuan","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.104054_bb0255","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jconrel.2023.01.026","article-title":"Influence of lung cancer model characteristics on tumor targeting behavior of nanodrugs","volume":"354","author":"Xu","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb0260","first-page":"1","article-title":"Nanomedicines: an update of diagnostic and therapeutic applications in multiple cancers","author":"Shinde","year":"2026","journal-title":"J Drug Target"},{"key":"10.1016\/j.cis.2026.104054_bb0265","doi-asserted-by":"crossref","first-page":"7649","DOI":"10.3390\/app15147649","article-title":"A narrative review on functionalized nanoparticles for the treatment and early detection of hepatocellular carcinoma","volume":"15","author":"Cosma","year":"2025","journal-title":"Appl Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0270","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40164-025-00658-z","article-title":"Engineered nanoparticles for imaging and targeted drug delivery in hepatocellular carcinoma","volume":"14","author":"Yu","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.cis.2026.104054_bb0275","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3389\/fonc.2021.789330","article-title":"Opportunities and challenges of nanoparticles in digestive tumours as anti-angiogenic therapies","volume":"11","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.cis.2026.104054_bb0280","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/jpm11060571","article-title":"Recent advances in tumor targeting via EPR effect for cancer treatment","volume":"11","author":"Subhan","year":"2021","journal-title":"J Person Med"},{"key":"10.1016\/j.cis.2026.104054_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.slast.2025.100362","article-title":"Nanomedicine for prostate cancer: modern therapies based on green synthesis of nanoparticles","volume":"35","author":"Aatif","year":"2025","journal-title":"SLAS Technol"},{"key":"10.1016\/j.cis.2026.104054_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114619","article-title":"Strategies to overcome\/penetrate the BBB for systemic nanoparticle delivery to the brain\/brain tumor","volume":"191","author":"Liu","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2026.104054_bb0295","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3390\/cancers17040701","article-title":"Progress in drug delivery systems based on nanoparticles for improved glioblastoma therapy: addressing challenges and investigating opportunities","volume":"17","author":"Rahman","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.cis.2026.104054_bb0300","doi-asserted-by":"crossref","first-page":"9597","DOI":"10.2147\/IJN.S531451","article-title":"Advances and challenges in nano-delivery systems for glioblastoma treatment: a comprehensive review","volume":"20","author":"Wang","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2026.104054_bb0305","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1927","article-title":"Current landscape of treating different cancers using nanomedicines: trends and perspectives","volume":"16","author":"Morales","year":"2024","journal-title":"WIREs Nanomed Nanobiotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb0310","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s44222-024-00203-3","article-title":"Nanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact","volume":"2","author":"Dasgupta","year":"2024","journal-title":"Nat Rev Bioeng"},{"key":"10.1016\/j.cis.2026.104054_bb0315","doi-asserted-by":"crossref","first-page":"0016","DOI":"10.34133\/bmef.0016","article-title":"Principles of nanoparticle delivery to solid tumors","volume":"4","author":"Chan","year":"2023","journal-title":"BME Front"},{"key":"10.1016\/j.cis.2026.104054_bb0320","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat Mater"},{"key":"10.1016\/j.cis.2026.104054_bb0325","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0169-409X(97)00080-X","article-title":"Endocytosis and transcytosis","volume":"29","author":"Okamoto","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2026.104054_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123315","article-title":"Strategies to enhance the penetration of nanomedicine in solid tumors","volume":"321","author":"Liu","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.cis.2026.104054_bb0335","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1152\/physrev.00001.2003","article-title":"Transcytosis: crossing cellular barriers","volume":"83","author":"Tuma","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cis.2026.104054_bb0340","doi-asserted-by":"crossref","first-page":"14080","DOI":"10.1021\/acsnano.1c04510","article-title":"Specific endothelial cells govern nanoparticle entry into solid tumors","volume":"15","author":"Kingston","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2026.104054_bb0345","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3390\/pharmaceutics15020519","article-title":"Intravital microscopy reveals endothelial transcytosis contributing to significant tumor accumulation of albumin nanoparticles","volume":"15","author":"Wei","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cis.2026.104054_bb0350","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.apsb.2025.11.040","article-title":"Exploiting eNOS activation to achieve tumor vascular normalization via endothelial transcytosis of lipid nanoparticles","volume":"16","author":"Hao","year":"2026","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.cis.2026.104054_bb0355","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41565-025-01877-5","article-title":"The pathways for nanoparticle transport across tumour endothelium","volume":"20","author":"Wu","year":"2025","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb0360","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/jlb.59.1.100","article-title":"The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation","volume":"59","author":"Dvorak","year":"1996","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cis.2026.104054_bb0365","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1084\/jem.183.5.1981","article-title":"Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin","volume":"183","author":"Feng","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.cis.2026.104054_bb0370","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/002215540104900401","article-title":"The Vesiculo\u2013Vacuolar Organelle (VVO): a new endothelial cell permeability organelle","volume":"49","author":"Dvorak","year":"2001","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.cis.2026.104054_bb0375","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1111\/j.1349-7006.2008.00974.x","article-title":"Inhibition of tumor-induced edema by antisense VEGF is mediated by suppressive vesiculo-vacuolar organelles (VVO) formation","volume":"99","author":"Lin","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0380","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1172\/JCI92284","article-title":"Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer","volume":"127","author":"Liu","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cis.2026.104054_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114480","article-title":"Transcytosis-enabled active extravasation of tumor nanomedicine","volume":"189","author":"Zhou","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2026.104054_bb0390","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3892\/etm.2016.3557","article-title":"Plasmalemma vesicle-associated protein: a crucial component of vascular homeostasis (Review)","volume":"12","author":"Guo","year":"2016","journal-title":"Exp Therap Med"},{"key":"10.1016\/j.cis.2026.104054_bb0395","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9440(10)63273-7","article-title":"Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts","volume":"165","author":"Inai","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cis.2026.104054_bb0400","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/j.1349-7006.2012.02412.x","article-title":"Tumor microvasculature with endothelial fenestrations in VHL null clear cell renal cell carcinomas as a potent target of anti-angiogenic therapy","volume":"103","author":"Yamasaki","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0405","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201606628","article-title":"Rational design of cancer nanomedicine: nanoproperty integration and synchronization","volume":"29","author":"Sun","year":"2017","journal-title":"Adv Mater"},{"key":"10.1016\/j.cis.2026.104054_bb0410","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/pharmaceutics12040371","article-title":"Endocytosis: the nanoparticle and submicron nanocompounds gateway into the cell","volume":"12","author":"Manzanares","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cis.2026.104054_bb0415","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1039\/D0CS01127D","article-title":"Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine","volume":"50","author":"Sousa de Almeida","year":"2021","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.cis.2026.104054_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101279","article-title":"Endocytosis of abiotic nanomaterials and nanobiovectors: inhibition of membrane trafficking","volume":"40","author":"Makvandi","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.cis.2026.104054_bb0425","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm3151","article-title":"Molecular mechanism and physiological functions of clathrin-mediated endocytosis","volume":"12","author":"McMahon","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.cis.2026.104054_bb0430","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41565-021-00858-8","article-title":"Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics","volume":"16","author":"Rennick","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb0435","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrm.2017.132","article-title":"Mechanisms of clathrin-mediated endocytosis","volume":"19","author":"Kaksonen","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.cis.2026.104054_bb0440","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/mt.2009.281","article-title":"The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls","volume":"18","author":"Vercauteren","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.cis.2026.104054_bb0445","doi-asserted-by":"crossref","first-page":"20993","DOI":"10.18632\/oncotarget.24772","article-title":"Cancer cellselective clathrinmediated endocytosis of aptamer decorated nanoparticles","volume":"9","author":"Engelberg","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.cis.2026.104054_bb0450","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1039\/D3TB00322A","article-title":"A computational study of the influence of nanoparticle shape on clathrin-mediated endocytosis","volume":"11","author":"Li","year":"2023","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.cis.2026.104054_bb0455","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1038\/s41467-026-72967-8","article-title":"Biomolecular condensates as protein degradation tools for intracellular targets","volume":"17","author":"Li","year":"2026","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.104054_bb0460","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1091\/mbc.e16-12-0871","article-title":"Selective regulation of clathrin-mediated epidermal growth factor receptor signaling and endocytosis by phospholipase C and calcium","volume":"28","author":"Delos Santos","year":"2017","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.cis.2026.104054_bb0465","article-title":"Advances in the mechanisms and applications of inhibitory oligodeoxynucleotides against immune-mediated inflammatory diseases","volume":"14","author":"Wang","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cis.2026.104054_bb0470","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.cell.2004.09.003","article-title":"Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic","volume":"118","author":"Pelkmans","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.cis.2026.104054_bb0475","series-title":"Methods in Membrane Lipids","first-page":"91","article-title":"Cholesterol depletion using methyl-\u03b2-cyclodextrin","author":"Mahammad","year":"2015"},{"key":"10.1016\/j.cis.2026.104054_bb0480","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/toxsci\/kfp087","article-title":"Mechanisms of quantum dot nanoparticle cellular uptake","volume":"110","author":"Zhang","year":"2009","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0485","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262211015","article-title":"Intracellular transport of monomeric peptides, (Poly)peptide-based coacervates and fibrils: mechanisms and prospects for drug delivery","volume":"26","author":"Vedekhina","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0490","doi-asserted-by":"crossref","first-page":"6778","DOI":"10.1021\/acs.jpcc.5b11059","article-title":"Nanoparticle multivalency directed shifting of cellular uptake mechanism","volume":"120","author":"Dalal","year":"2016","journal-title":"J Phys Chem C"},{"key":"10.1016\/j.cis.2026.104054_bb0495","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1158\/0008-5472.CAN-17-0604","article-title":"Caveolae-mediated endocytosis is critical for albumin cellular uptake and response to albumin-bound chemotherapy","volume":"77","author":"Chatterjee","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.cis.2026.104054_bb0500","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2407-9-65","article-title":"Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion","volume":"9","author":"Cokakli","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cis.2026.104054_bb0505","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202205122","article-title":"Dynamin2 functions as an accessory protein to reduce the rate of caveola internalization","volume":"222","author":"Larsson","year":"2023","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cis.2026.104054_bb0510","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nature14067","article-title":"Endophilin marks and controls a clathrin-independent endocytic pathway","volume":"517","author":"Boucrot","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cis.2026.104054_bb0515","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/anie.201409161","article-title":"Direct cytosolic delivery of siRNA using nanoparticle-stabilized nanocapsules","volume":"54","author":"Jiang","year":"2015","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.cis.2026.104054_bb0520","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.xphs.2023.10.018","article-title":"Uptake pathway of styrene maleic acid copolymer-coated lipid emulsions under acidic tumor microenvironment","volume":"113","author":"Hosokawa","year":"2024","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0525","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ceb.2011.03.007","article-title":"Clathrin-independent endocytosis: mechanisms and function","volume":"23","author":"Sandvig","year":"2011","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.cis.2026.104054_bb0530","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.2147\/IJN.S274289","article-title":"Endocytosis and organelle targeting of nanomedicines in cancer therapy","volume":"15","author":"Wang","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2026.104054_bb0535","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48370-3","article-title":"Non-professional phagocytosis: a general feature of normal tissue cells","volume":"9","author":"Seeberg","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.cis.2026.104054_bb0540","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s00018-009-0053-z","article-title":"Nanocarriers\u2019 entry into the cell: relevance to drug delivery","volume":"66","author":"Hillaireau","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0545","doi-asserted-by":"crossref","first-page":"7542","DOI":"10.3390\/curroncol30080547","article-title":"Non-professional phagocytosis increases in melanoma cells and tissues with increasing E-cadherin expression","volume":"30","author":"Unseld","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.cis.2026.104054_bb0550","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1038\/s41467-021-26694-x","article-title":"Gold nanoparticles enhance antibody effect through direct cancer cell cytotoxicity by differential regulation of phagocytosis","volume":"12","author":"Fan","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.104054_bb0555","first-page":"14","article-title":"Macropinocytosis: mechanism and targeted therapy in cancers","volume":"11","author":"Xiao","year":"2021","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.cis.2026.104054_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100993","article-title":"Revealing macropinocytosis using nanoparticles","volume":"83","author":"Means","year":"2022","journal-title":"Mol Asp Med"},{"key":"10.1016\/j.cis.2026.104054_bb0565","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jconrel.2020.10.049","article-title":"Macropinocytosis as a cell entry route for peptide-functionalized and bystander nanoparticles","volume":"329","author":"Li","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb0570","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.trecan.2019.04.002","article-title":"Macropinocytosis in cancer: a complex signaling network","volume":"5","author":"Zhang","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.cis.2026.104054_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125356","article-title":"Endocytic highways: navigating macropinocytosis and other endocytic routes for precision drug delivery","volume":"673","author":"Neupane","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2026.104054_bb0580","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nature12138","article-title":"Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells","volume":"497","author":"Commisso","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cis.2026.104054_bb0585","doi-asserted-by":"crossref","first-page":"14461","DOI":"10.1021\/jacs.0c02109","article-title":"Macropinocytosis as a key determinant of peptidomimetic uptake in cancer cells","volume":"142","author":"Yoo","year":"2020","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cis.2026.104054_bb0590","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev-cellbio-100617-062710","article-title":"Spoiled for choice: diverse endocytic pathways function at the cell surface","volume":"35","author":"Thottacherry","year":"2019","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.cis.2026.104054_bb0595","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2016.00381","article-title":"Macropinocytosis exploitation by cancers and cancer therapeutics","volume":"7","author":"Ha","year":"2016","journal-title":"Front Physiol"},{"key":"10.1016\/j.cis.2026.104054_bb0600","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2019.04.008","article-title":"Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine","volume":"143","author":"Donahue","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2026.104054_bb0605","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","article-title":"Cell-penetrating peptides: from basic research to clinics","volume":"38","author":"Guidotti","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0610","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1039\/D5PM00129C","article-title":"Breaking the cellular delivery bottleneck: recent developments in direct cytosolic delivery of biologics","volume":"2","author":"Nagaraj","year":"2025","journal-title":"RSC Pharm"},{"key":"10.1016\/j.cis.2026.104054_bb0615","doi-asserted-by":"crossref","first-page":"15819","DOI":"10.1021\/acsami.3c18750","article-title":"Direct membrane penetration and cytosolic delivery of nanoparticles via electrostatically bound amphiphiles","volume":"16","author":"Ray","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.cis.2026.104054_bb0620","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/s41565-024-01785-0","article-title":"Direct cytosolic delivery of siRNA via cell membrane fusion using cholesterol-enriched exosomes","volume":"19","author":"Zhuo","year":"2024","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb0625","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1038\/s41467-025-61230-1","article-title":"Bioengineered nanovesicles for efficient siRNA delivery through ligand-receptor-mediated and enzyme-controlled membrane fusion","volume":"16","author":"Cui","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.104054_bb0630","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/s41565-024-01769-0","article-title":"Polymer-locking fusogenic liposomes for glioblastoma-targeted siRNA delivery and CRISPR\u2013Cas gene editing","volume":"19","author":"Zhao","year":"2024","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb0635","doi-asserted-by":"crossref","first-page":"9788","DOI":"10.1039\/D2RA07111H","article-title":"Recent progress in nanomedicine-mediated cytosolic delivery","volume":"13","author":"Son","year":"2023","journal-title":"RSC Adv"},{"key":"10.1016\/j.cis.2026.104054_bb0640","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-biophys-052118-115451","article-title":"Membrane electroporation and electropermeabilization: mechanisms and models","volume":"48","author":"Kotnik","year":"2019","journal-title":"Annu Rev Biophys"},{"key":"10.1016\/j.cis.2026.104054_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2022.106819","article-title":"Electroporation, electrochemotherapy and electro-assisted drug delivery in cancer. A state-of-the-art review","volume":"286","author":"Tsoneva","year":"2022","journal-title":"Biophys Chem"},{"key":"10.1016\/j.cis.2026.104054_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114042","article-title":"Delivery of CRISPR-Cas9 system for screening and editing RNA binding proteins in cancer","volume":"180","author":"Yan","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2026.104054_bb0655","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1038\/s41467-024-48608-3","article-title":"Single molecule delivery into living cells","volume":"15","author":"Chau","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.104054_bb0660","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","article-title":"Endocytosis of nanomedicines","volume":"145","author":"Sahay","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb0665","doi-asserted-by":"crossref","first-page":"9186","DOI":"10.1021\/acs.jpcb.1c05931","article-title":"Phosphate-dependent colloidal stability controls nonendocytic cell delivery of arginine-terminated nanoparticles","volume":"125","author":"Ray","year":"2021","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.cis.2026.104054_bb0670","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1021\/acs.jpclett.0c00176","article-title":"Arginine-terminated nanoparticles of <10 nm size for direct membrane penetration and protein delivery for straight access to cytosol and nucleus","volume":"11","author":"Panja","year":"2020","journal-title":"J Phys Chem Lett"},{"key":"10.1016\/j.cis.2026.104054_bb0675","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/ijms26010002","article-title":"Cancer-targeting applications of cell-penetrating peptides","volume":"26","author":"Moreno-Vargas","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0680","doi-asserted-by":"crossref","first-page":"20006","DOI":"10.1039\/D5NR00617A","article-title":"Cell-penetrating peptides as facilitators of cargo-specific nanocarrier-based drug delivery","volume":"17","author":"Jankowski","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.cis.2026.104054_bb0685","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1021\/acs.accounts.7b00221","article-title":"Cell-surface interactions on arginine-rich cell-penetrating peptides allow for multiplex modes of internalization","volume":"50","author":"Futaki","year":"2017","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.cis.2026.104054_bb0690","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/nn4057269","article-title":"Cell-penetrating peptides: design, synthesis, and applications","volume":"8","author":"Copolovici","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2026.104054_bb0695","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2017.04.013","article-title":"Membrane permeation of arginine-rich cell-penetrating peptides independent of transmembrane potential as a function of lipid composition and membrane fluidity","volume":"256","author":"Wallbrecher","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb0700","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1074\/jbc.M503202200","article-title":"High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression","volume":"281","author":"Khalil","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cis.2026.104054_bb0705","doi-asserted-by":"crossref","first-page":"29065","DOI":"10.1039\/D1RA04431A","article-title":"NIR-triggered upconversion nanoparticles@thermo-sensitive liposome hybrid theranostic nanoplatform for controlled drug delivery","volume":"11","author":"Yu","year":"2021","journal-title":"RSC Adv"},{"key":"10.1016\/j.cis.2026.104054_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103920","article-title":"Improving viral-based gene delivery to mammalian cells through simple co-incubation with transportan peptide in vitro","volume":"114","author":"Wang","year":"2025","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0715","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1096\/fsb2fasebj.12.1.67","article-title":"Cell penetration by transportan","volume":"12","author":"Pooga","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.cis.2026.104054_bb0720","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/nar\/gkg385","article-title":"Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells","volume":"31","author":"Simeoni","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cis.2026.104054_bb0725","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1074\/jbc.M509813200","article-title":"Mechanism of uptake of C105Y, a novel cell-penetrating peptide *","volume":"281","author":"Rhee","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cis.2026.104054_bb0730","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2217\/nnm.14.235","article-title":"Functionalization of mesoporous silica nanoparticles with a cell-penetrating peptide to target mammalian sperm in vitro","volume":"10","author":"Barkalina","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.cis.2026.104054_bb0735","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01303","article-title":"p28 bacterial peptide, as an anticancer agent","volume":"10","author":"Yaghoubi","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.cis.2026.104054_bb0740","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jconrel.2021.07.035","article-title":"p28-functionalized PLGA nanoparticles loaded with gefitinib reduce tumor burden and metastases formation on lung cancer","volume":"337","author":"Garizo","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb0745","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1021\/acs.biochem.6b00226","article-title":"Discovery and mechanism of highly efficient cyclic cell-penetrating peptides","volume":"55","author":"Qian","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.cis.2026.104054_bb0750","doi-asserted-by":"crossref","first-page":"8735","DOI":"10.1016\/j.biomaterials.2014.06.042","article-title":"Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates","volume":"35","author":"Wang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.cis.2026.104054_bb0755","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fonc.2013.00216","article-title":"Tumor-penetrating peptides","volume":"3","author":"Teesalu","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.cis.2026.104054_bb0760","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1158\/0008-5472.CAN-12-1668","article-title":"De novo design of a tumor-penetrating peptide","volume":"73","author":"Alberici","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.cis.2026.104054_bb0765","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1021\/acsnano.8b00081","article-title":"Self-assembled peptide\u2013lanthanide nanoclusters for safe tumor therapy: overcoming and utilizing biological barriers to peptide drug delivery","volume":"12","author":"Yan","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2026.104054_bb0770","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.actbio.2019.02.009","article-title":"Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer","volume":"88","author":"Jiang","year":"2019","journal-title":"Acta Biomater"},{"key":"10.1016\/j.cis.2026.104054_bb0775","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1039\/D0MA00203H","article-title":"Synthesis and characterization of a tumor-seeking LyP-1 peptide integrated lipid\u2013polymer composite nanoparticle","volume":"1","author":"Marasini","year":"2020","journal-title":"Mater Adv"},{"key":"10.1016\/j.cis.2026.104054_bb0780","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3390\/ijms21072536","article-title":"Nanoparticles modified with cell-penetrating peptides: conjugation mechanisms, physicochemical properties, and application in cancer diagnosis and therapy","volume":"21","author":"Gessner","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0785","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1038\/bjc.2013.266","article-title":"p28, A first in class peptide inhibitor of cop1 binding to p53","volume":"108","author":"Yamada","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cis.2026.104054_bb0790","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3762\/bjnano.11.10","article-title":"Internalization mechanisms of cell-penetrating peptides","volume":"11","author":"Ruseska","year":"2020","journal-title":"Beilstein J Nanotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb0795","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.3390\/cancers16223768","article-title":"Enhancing tumor targeted therapy: the role of irgd peptide in advanced drug delivery systems","volume":"16","author":"Nikitovic","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.cis.2026.104054_bb0800","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3390\/polym12091906","article-title":"iRGD peptide as a tumor-penetrating enhancer for tumor-targeted drug delivery","volume":"12","author":"Kang","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.cis.2026.104054_bb0805","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1038\/ncomms5904","article-title":"An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability","volume":"5","author":"Pang","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.104054_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106200","article-title":"tLyp\u20131: a peptide suitable to target NRP\u20131 receptor","volume":"130","author":"Larue","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.cis.2026.104054_bb0815","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1172\/JCI93955","article-title":"Access granted: iRGD helps silicasome-encased drugs breach the tumor barrier","volume":"127","author":"Ruoslahti","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cis.2026.104054_bb0820","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/acsnano.5c18112","article-title":"The biology of endosomal escape: strategies for enhanced delivery of therapeutics","volume":"20","author":"Chahal","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2026.104054_bb0825","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape: a bottleneck for LNP-mediated therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0830","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1038\/s41467-021-23997-x","article-title":"Unravelling cytosolic delivery of cell penetrating peptides with a quantitative endosomal escape assay","volume":"12","author":"Teo","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.104054_bb0835","article-title":"Endosomal escape of delivered mRNA from endosomal recycling tubules visualized at the nanoscale","volume":"221","author":"Paramasivam","year":"2021","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cis.2026.104054_bb0840","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202310355","article-title":"Engineered histidine-rich peptides enhance endosomal escape for antibody-targeted intracellular delivery of functional proteins","volume":"62","author":"Zhao","year":"2023","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.cis.2026.104054_bb0845","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201601412","article-title":"Arginine-rich peptide-based mRNA nanocomplexes efficiently instigate cytotoxic T cell immunity dependent on the amphipathic organization of the peptide","volume":"6","author":"Udhayakumar","year":"2017","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.cis.2026.104054_bb0850","doi-asserted-by":"crossref","first-page":"11923","DOI":"10.1073\/pnas.1811520115","article-title":"Arginine-rich cell-penetrating peptides induce membrane multilamellarity and subsequently enter via formation of a fusion pore","volume":"115","author":"Allolio","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0855","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1021\/acs.biochem.8b00764","article-title":"The stabilities of the soluble ectodomain and fusion peptide hairpins of the influenza virus hemagglutinin subunit ii protein are positively correlated with membrane fusion","volume":"57","author":"Ranaweera","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.cis.2026.104054_bb0860","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1021\/acschembio.0c00478","article-title":"Cell-penetrating peptides escape the endosome by inducing vesicle budding and collapse","volume":"15","author":"Sahni","year":"2020","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.cis.2026.104054_bb0865","doi-asserted-by":"crossref","first-page":"11159","DOI":"10.1021\/acsami.3c14908","article-title":"Cell-penetrating and enzyme-responsive peptides for targeted cancer therapy: role of arginine residue length on cell penetration and in vivo systemic toxicity","volume":"16","author":"Ghaemi","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.cis.2026.104054_bb0870","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1021\/acs.molpharmaceut.0c00394","article-title":"Factors influencing the immunogenicity and immunotoxicity of cyclic RGD peptide-modified nanodrug delivery systems","volume":"17","author":"Wang","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1016\/j.cis.2026.104054_bb0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175192","article-title":"In vivo degradation forms, anti-degradation strategies, and clinical applications of therapeutic peptides in non-infectious chronic diseases","volume":"932","author":"Tasdemiroglu","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cis.2026.104054_bb0880","first-page":"172","article-title":"D-amino acid substitution and cyclization enhance the stability and antimicrobial activity of arginine-rich peptides","author":"Mendes","year":"2026","journal-title":"Microbiology"},{"key":"10.1016\/j.cis.2026.104054_bb0885","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2147\/IJN.S343902","article-title":"iRGD tumor-penetrating peptide-modified nano-delivery system based on a marine sulfated polysaccharide for enhanced anti-tumor efficiency against breast cancer","volume":"17","author":"Chen","year":"2022","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2026.104054_bb0890","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12951-026-04028-7","article-title":"Overcoming tumor microenvironment barriers: transformable and bioinspired nanomedicine strategies for deep tumor penetration","volume":"24","author":"Sheng","year":"2026","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb0895","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1038\/s41598-025-86130-8","article-title":"Advances and prospects of cell-penetrating peptides in tumor immunotherapy","volume":"15","author":"Yang","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.cis.2026.104054_bb0900","doi-asserted-by":"crossref","first-page":"27458","DOI":"10.1021\/acsami.5b09391","article-title":"A novel strategy through combining iRGD peptide with tumor-microenvironment-responsive and multistage nanoparticles for deep tumor penetration","volume":"7","author":"Cun","year":"2015","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.cis.2026.104054_bb0905","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.biomaterials.2012.12.040","article-title":"Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles","volume":"34","author":"Pan","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.cis.2026.104054_bb0910","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3727\/000000006783980946","article-title":"TAT peptide-modified liposomes provide enhanced gene delivery to intracranial human brain tumor xenografts in nude mice","volume":"16","author":"Gupta","year":"2007","journal-title":"Oncol Res"},{"key":"10.1016\/j.cis.2026.104054_bb0915","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/cbdd.13323","article-title":"Co-administration of kla-TAT peptide and iRGD to enhance the permeability on A549 3D multiple sphere cells and accumulation on xenograft mice","volume":"92","author":"Hu","year":"2018","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.cis.2026.104054_bb0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2025.216848","article-title":"Inorganic nanoparticle-based cancer immunotheranostics","volume":"542","author":"Lee","year":"2025","journal-title":"Coord Chem Rev"},{"key":"10.1016\/j.cis.2026.104054_bb0925","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.192","article-title":"Targeting inorganic nanoparticles to tumors using biological membrane-coated technology","volume":"3","author":"Zhang","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.cis.2026.104054_bb0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2025.217049","article-title":"Metal coordination-based nanomaterials: novel drug delivery system for treatment of rheumatoid arthritis","volume":"546","author":"Coghi","year":"2026","journal-title":"Coord Chem Rev"},{"key":"10.1016\/j.cis.2026.104054_bb0935","doi-asserted-by":"crossref","first-page":"13595","DOI":"10.1021\/acs.analchem.0c03476","article-title":"Bifunctional peptide-conjugated gold nanoparticles for precise and efficient nucleus-targeting bioimaging in live cells","volume":"92","author":"Gao","year":"2020","journal-title":"Anal Chem"},{"key":"10.1016\/j.cis.2026.104054_bb0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2026.173100","article-title":"O2-supplementing photosensitizer AuNCs@TAT as a highly efficient NIR-II-controllable pyroptosis inducer for cancer photoimmunotherapy","volume":"529","author":"Xie","year":"2026","journal-title":"Chem Eng J"},{"key":"10.1016\/j.cis.2026.104054_bb0945","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.cis.2026.104054_bb0950","doi-asserted-by":"crossref","first-page":"41792","DOI":"10.1021\/acsami.5c09286","article-title":"Platinum(IV) prodrug-coupled TAT nuclear-targeting peptide for drug delivery and high antitumor efficacy with low toxicity","volume":"17","author":"Li","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.cis.2026.104054_bb0955","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jconrel.2024.03.057","article-title":"Disrupting glycolysis and DNA repair in anaplastic thyroid cancer with nucleus-targeting platinum nanoclusters","volume":"369","author":"Pan","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb0960","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","article-title":"Polymeric nanoparticles for drug delivery","volume":"124","author":"Beach","year":"2024","journal-title":"Chem Rev"},{"key":"10.1016\/j.cis.2026.104054_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101046","article-title":"Polymers and inorganic nanoparticles: a winning combination towards assembled nanostructures for cancer imaging and therapy","volume":"36","author":"Yang","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.cis.2026.104054_bb0970","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jcis.2023.05.031","article-title":"Autophagy-induced intracellular signaling fractional nano-drug system for synergistic anti-tumor therapy","volume":"645","author":"Yan","year":"2023","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.cis.2026.104054_bb0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122213","article-title":"Enzyme-triggered transcytosis of drug carrier system for deep penetration into hepatoma tumors","volume":"301","author":"Yan","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.cis.2026.104054_bb0980","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2024.101906","article-title":"Cell-penetrating peptides with nanoparticles hybrid delivery vectors and their uptake pathways","volume":"78","author":"Dowaidar","year":"2024","journal-title":"Mitochondrion"},{"key":"10.1016\/j.cis.2026.104054_bb0985","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1016\/j.biomaterials.2013.03.047","article-title":"Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles","volume":"34","author":"Yang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.cis.2026.104054_bb0990","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.biopha.2016.10.003","article-title":"TAT modified and lipid \u2013 PEI hybrid nanoparticles for co-delivery of docetaxel and pDNA","volume":"84","author":"Dong","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cis.2026.104054_bb0995","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s12951-022-01530-6","article-title":"GRP75-driven, cell-cycle-dependent macropinocytosis of Tat\/pDNA-Ca2+ nanoparticles underlies distinct gene therapy effect in ovarian cancer","volume":"20","author":"Su","year":"2022","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb1000","doi-asserted-by":"crossref","DOI":"10.1002\/anie.4706958","article-title":"Benzaldehyde-tagged cell-penetrating peptides enable efficient cytosolic delivery of bioactive cargos via dynamic covalent anchoring","volume":"65","author":"Feng","year":"2026","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.cis.2026.104054_bb1005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2016.03.008","article-title":"Tumor penetrating peptides for improved drug delivery","volume":"110-111","author":"Ruoslahti","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2026.104054_bb1010","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.bulcan.2023.08.009","article-title":"Cancer therapy with iRGD as a tumor-penetrating peptide","volume":"110","author":"Thirumalai","year":"2023","journal-title":"Bull Cancer"},{"key":"10.1016\/j.cis.2026.104054_bb1015","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jconrel.2024.11.061","article-title":"Nanoparticulate drug combination inhibits DNA damage repair and PD-L1 expression in BRCA-mutant and wild type triple-negative breast cancer","volume":"377","author":"Alradwan","year":"2025","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb1020","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1186\/s12967-025-06735-5","article-title":"Enhancing doxorubicin sensitivity in osteosarcoma via iRGD-modified biomimetic nanoparticles targeting MCAM m6A modification","volume":"23","author":"Song","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.cis.2026.104054_bb1025","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202300067","article-title":"iRGD-targeted physalis mottle virus like nanoparticles for targeted cancer delivery","volume":"3","author":"Barkovich","year":"2023","journal-title":"Small Sci"},{"key":"10.1016\/j.cis.2026.104054_bb1030","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3390\/pharmaceutics15020614","article-title":"Dual effect of chemo-PDT with tumor targeting nanoparticles containing iRGD peptide","volume":"15","author":"Kim","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cis.2026.104054_bb1035","article-title":"A Novel tumor-penetrating phosphorescent nanoagent for hypoxia-activated NIR-II bioimaging and type-I PDT-triggered ferroptosis","author":"Zhang","year":"2026","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.cis.2026.104054_bb1040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13045-020-00885-3","article-title":"Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy","volume":"13","author":"Li","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.cis.2026.104054_bb1045","doi-asserted-by":"crossref","first-page":"22665","DOI":"10.1021\/acs.jmedchem.5c01632","article-title":"Rational design of PROTAC degraders and their spatiotemporal controlled delivery for enhanced tumor penetration and PD-L1 Protein degradation","volume":"68","author":"Qi","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.cis.2026.104054_bb1050","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.biomaterials.2015.02.084","article-title":"Single-component self-assembled RNAi nanoparticles functionalized with tumor-targeting iNGR delivering abundant siRNA for efficient glioma therapy","volume":"53","author":"An","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.cis.2026.104054_bb1055","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/10717544.2019.1587047","article-title":"Recent progress in LyP-1-based strategies for targeted imaging and therapy","volume":"26","author":"Song","year":"2019","journal-title":"Drug Deliv"},{"key":"10.1016\/j.cis.2026.104054_bb1060","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2016.07.020","article-title":"Plaque-penetrating peptide inhibits development of hypoxic atherosclerotic plaque","volume":"238","author":"She","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb1065","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.actbio.2021.12.014","article-title":"Tumor microcalcification-mediated relay drug delivery for photodynamic immunotherapy of breast cancer","volume":"140","author":"Jian","year":"2022","journal-title":"Acta Biomater"},{"key":"10.1016\/j.cis.2026.104054_bb1070","article-title":"An intelligent vascular disrupting dendritic nanodevice incorporating copper sulfide nanoparticles for immune modulation-mediated combination tumor therapy","volume":"19","author":"Zhang","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.cis.2026.104054_bb1075","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1039\/c3sc51328a","article-title":"Helical poly(arginine) mimics with superior cell-penetrating and molecular transporting properties","volume":"4","author":"Tang","year":"2013","journal-title":"Chem Sci"},{"key":"10.1016\/j.cis.2026.104054_bb1080","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1021\/acs.jpcb.8b10483","article-title":"Improved intracellular delivery of polyarginine peptides with cargoes","volume":"123","author":"Hu","year":"2019","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.cis.2026.104054_bb1085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jconrel.2012.01.016","article-title":"Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo","volume":"159","author":"Nakase","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb1090","series-title":"Polymeric Nanoparticles as a Promising Tool for Anti-Cancer Therapeutics","first-page":"167","article-title":"Chapter 9 - Poly(Amino Acid) nanoparticles as a promising tool for anticancer therapeutics","author":"Abdelaziz","year":"2019"},{"key":"10.1016\/j.cis.2026.104054_bb1095","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jconrel.2016.04.040","article-title":"Bioreducible branched poly(modified nona-arginine) cell-penetrating peptide as a novel gene delivery platform","volume":"246","author":"Yoo","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb1100","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202409081","article-title":"Enhanced tumor-targeted delivery of arginine-rich peptides via a positive feedback loop orchestrated by piezo1\/integrin \u03b21 signaling axis","volume":"11","author":"Ma","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.cis.2026.104054_bb1105","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1520078","article-title":"Nanoparticle accumulation and penetration in 3D tumor models: the effect of size, shape, and surface charge","volume":"12","author":"Cybulski","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.cis.2026.104054_bb1110","doi-asserted-by":"crossref","first-page":"8483","DOI":"10.2147\/IJN.S148359","article-title":"Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy","volume":"12","author":"Zhang","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2026.104054_bb1115","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/nbt1340","article-title":"Renal clearance of quantum dots","volume":"25","author":"Soo Choi","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb1120","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb1125","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202202242","article-title":"Size optimization of organic nanoparticles with aggregation-induced emission characteristics for improved ROS generation and photodynamic cancer cell ablation","volume":"18","author":"Gan","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.cis.2026.104054_bb1130","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1021\/acs.nanolett.7b00021","article-title":"Mediating passive tumor accumulation through particle size, tumor type, and location","volume":"17","author":"Perry","year":"2017","journal-title":"Nano Lett"},{"key":"10.1016\/j.cis.2026.104054_bb1135","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.apsb.2024.11.012","article-title":"Size-transformable nanotherapeutics for cancer therapy","volume":"15","author":"Ma","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.cis.2026.104054_bb1140","doi-asserted-by":"crossref","first-page":"38048","DOI":"10.1021\/acsami.2c05750","article-title":"Size-controllable DNA origami-stacked gold nanoparticles for deep tumor-penetrating therapy","volume":"14","author":"Gu","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.cis.2026.104054_bb1145","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1021\/nn304439f","article-title":"Nanoparticle geometry and surface orientation influence mode of cellular uptake","volume":"7","author":"Herd","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2026.104054_bb1150","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1039\/C5SM01793A","article-title":"The role of membrane curvature for the wrapping of nanoparticles","volume":"12","author":"Bahrami","year":"2016","journal-title":"Soft Matter"},{"key":"10.1016\/j.cis.2026.104054_bb1155","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1021\/nl403949h","article-title":"Shape and orientation matter for the cellular uptake of nonspherical particles","volume":"14","author":"Dasgupta","year":"2014","journal-title":"Nano Lett"},{"key":"10.1016\/j.cis.2026.104054_bb1160","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20220075","article-title":"The flow of anisotropic nanoparticles in solution and in blood","volume":"3","author":"Lovegrove","year":"2023","journal-title":"Exploration"},{"key":"10.1016\/j.cis.2026.104054_bb1165","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1039\/D2RA06888E","article-title":"Effects of morphology and size of nanoscale drug carriers on cellular uptake and internalization process: a review","volume":"13","author":"Zhang","year":"2023","journal-title":"RSC Adv"},{"key":"10.1016\/j.cis.2026.104054_bb1170","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.actbio.2025.06.027","article-title":"Discoidal nanoparticles exploit thrombus-induced shear gradients to enhance site-specific thrombolysis in stroke","volume":"201","author":"Liu","year":"2025","journal-title":"Acta Biomater"},{"key":"10.1016\/j.cis.2026.104054_bb1175","article-title":"Shape-regulated photothermal-catalytic tumor therapy using polydopamine@PT nanozymes with the elicitation of an immune response","volume":"20","author":"Xu","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.cis.2026.104054_bb1180","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.apsb.2020.10.009","article-title":"GSH-responsive SN38 dimer-loaded shape-transformable nanoparticles with iRGD for enhancing chemo-photodynamic therapy","volume":"10","author":"Lin","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.cis.2026.104054_bb1185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124799","article-title":"Effects of nanoparticle size, shape, and zeta potential on drug delivery","volume":"666","author":"\u00d6zt\u00fcrk","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2026.104054_bb1190","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/jfb13040196","article-title":"Overview of physicochemical properties of nanoparticles as drug carriers for targeted cancer therapy","volume":"13","author":"Yagublu","year":"2022","journal-title":"J Funct Biomater"},{"key":"10.1016\/j.cis.2026.104054_bb1195","article-title":"Exploring the frontier of oral nanomedicine in colorectal cancer therapy: Folate-targeted 5FU-Nisin-Selenium conjugates and probiotic-rich diets as a novel approach","volume":"20","author":"Derakhshan-sefidi","year":"2025","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.cis.2026.104054_bb1200","article-title":"CaO2-powered nanomotors with enhanced cellular uptake and lysosomal escape for cuproptosis and reactive oxygen species-mediated synergistic cancer therapy","author":"Ma","year":"2026","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.cis.2026.104054_bb1205","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1021\/acsami.4c20103","article-title":"Dendrimer-mediated generation of a metal-phenolic network for antibody delivery to elicit improved tumor chemo\/chemodynamic\/immune therapy","volume":"17","author":"Wang","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.cis.2026.104054_bb1210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jconrel.2014.02.011","article-title":"Glycosaminoglycans in the cellular uptake of drug delivery vectors \u2013 Bystanders or active players?","volume":"180","author":"Favretto","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb1215","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.cis.2026.104054_bb1220","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1021\/acs.bioconjchem.9b00136","article-title":"Penetration and uptake of nanoparticles in 3D tumor spheroids","volume":"30","author":"Tchoryk","year":"2019","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.cis.2026.104054_bb1225","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41467-017-02588-9","article-title":"Nanoparticle elasticity directs tumor uptake","volume":"9","author":"Guo","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.104054_bb1230","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1021\/acsnano.5b00147","article-title":"Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting","volume":"9","author":"Anselmo","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2026.104054_bb1235","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1021\/acsnano.8b00242","article-title":"Understanding the effects of nanocapsular mechanical property on passive and active tumor targeting","volume":"12","author":"Hui","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2026.104054_bb1240","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1039\/C6NR07179A","article-title":"Kinetics of receptor-mediated endocytosis of elastic nanoparticles","volume":"9","author":"Yi","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.cis.2026.104054_bb1245","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2104826118","article-title":"Stiffness of targeted layer-by-layer nanoparticles impacts elimination half-life, tumor accumulation, and tumor penetration","volume":"118","author":"Kong","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cis.2026.104054_bb1250","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1021\/cbe.4c00105","article-title":"Protein corona of nanoparticles: isolation and analysis","volume":"1","author":"Sun","year":"2024","journal-title":"Chem Bio Eng"},{"key":"10.1016\/j.cis.2026.104054_bb1255","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.103046","article-title":"Impact of protein coronas on nanoparticle interactions with tissues and targeted delivery","volume":"85","author":"Chou","year":"2024","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb1260","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1021\/ja107583h","article-title":"Physical\u2212chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles","volume":"133","author":"Monopoli","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cis.2026.104054_bb1265","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1039\/D2LC00799A","article-title":"Nanoparticle protein corona: from structure and function to therapeutic targeting","volume":"23","author":"Bashiri","year":"2023","journal-title":"Lab Chip"},{"key":"10.1016\/j.cis.2026.104054_bb1270","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.jcis.2021.08.148","article-title":"Influence of nanoparticle mechanical property on protein corona formation","volume":"606","author":"Tengjisi","year":"2022","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.cis.2026.104054_bb1275","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nnano.2012.237","article-title":"Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface","volume":"8","author":"Salvati","year":"2013","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb1280","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1039\/D0AN00633E","article-title":"Engineering at the nano-bio interface: harnessing the protein corona towards nanoparticle design and function","volume":"145","author":"Pinals","year":"2020","journal-title":"Analyst"},{"key":"10.1016\/j.cis.2026.104054_bb1285","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jconrel.2022.03.056","article-title":"The Janus of Protein Corona on nanoparticles for tumor targeting, immunotherapy and diagnosis","volume":"345","author":"Wang","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb1290","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102307","article-title":"Impact of protein corona and PEGylation on the accumulation and efficacy of lysosome-disrupting lipid nanoparticles in KRAS-mutated cancer","volume":"56","author":"Yang","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.cis.2026.104054_bb1295","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/jacs.5c19355","article-title":"Cancer cells degrade the nanoparticle protein corona for biosynthesis","volume":"148","author":"Ji","year":"2026","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cis.2026.104054_bb1300","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114733","article-title":"Protein corona-guided delivery of dextran-PLGA NPs for enhanced dendritic cell uptake, maturation and improved cancer immunotherapy","volume":"392","author":"Vu","year":"2026","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb1305","first-page":"401","article-title":"Changes in target ability of nanoparticles due to protein corona composition and disease state","volume":"17","author":"Xu","year":"2022","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.cis.2026.104054_bb1310","doi-asserted-by":"crossref","first-page":"17254","DOI":"10.1039\/C7NR06437C","article-title":"An apolipoprotein-enriched biomolecular corona switches the cellular uptake mechanism and trafficking pathway of lipid nanoparticles","volume":"9","author":"Digiacomo","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.cis.2026.104054_bb1315","doi-asserted-by":"crossref","first-page":"11107","DOI":"10.1021\/acsnano.9b03824","article-title":"Corona composition can affect the mechanisms cells use to internalize nanoparticles","volume":"13","author":"Francia","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2026.104054_bb1320","doi-asserted-by":"crossref","first-page":"9123","DOI":"10.3390\/ijms21239123","article-title":"Aptamer-functionalized nanoparticles in targeted delivery and cancer therapy","volume":"21","author":"Fu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2026.104054_bb1325","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1021\/acs.molpharmaceut.9b00250","article-title":"A look at receptor\u2013ligand pairs for active-targeting drug delivery from crystallographic and molecular dynamics perspectives","volume":"16","author":"Gocheva","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.cis.2026.104054_bb1330","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155955","article-title":"Unlocking the potential: receptor-mediated targeted drug delivery in cancer therapy","volume":"270","author":"Palanisamy","year":"2025","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.cis.2026.104054_bb1335","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2015.04.035","article-title":"The effect of ligand density on in vivo tumor targeting of nanographene oxide","volume":"209","author":"Lee","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb1340","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13818","article-title":"Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies","volume":"7","author":"Colombo","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.104054_bb1345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114598","article-title":"The effects of ligand distribution and density on the targeting properties of dual-targeting folate\/biotin Pluronic F127\/Poly (lactic acid) polymersomes","volume":"206","author":"Wang","year":"2025","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.cis.2026.104054_bb1350","doi-asserted-by":"crossref","first-page":"9935","DOI":"10.1039\/C8NR00640G","article-title":"A size switchable nanoplatform for targeting the tumor microenvironment and deep tumor penetration","volume":"10","author":"Cun","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.cis.2026.104054_bb1355","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.actbio.2017.08.025","article-title":"Improved tumor tissue penetration and tumor cell uptake achieved by delayed charge reversal nanoparticles","volume":"62","author":"Gou","year":"2017","journal-title":"Acta Biomater"},{"key":"10.1016\/j.cis.2026.104054_bb1360","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41467-023-37150-3","article-title":"Mechano-boosting nanomedicine antitumour efficacy by blocking the reticuloendothelial system with stiff nanogels","volume":"14","author":"Li","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.104054_bb1365","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2026.115538","article-title":"Apolipoprotein E-enriched protein corona enhances the blood\u2013brain barrier transport of \u03b2-sheet-breaker peptide-functionalized gold nanoparticles","volume":"262","author":"Guerrero","year":"2026","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"10.1016\/j.cis.2026.104054_bb1370","doi-asserted-by":"crossref","first-page":"538","DOI":"10.7150\/thno.16684","article-title":"Current multistage drug delivery systems based on the tumor microenvironment","volume":"7","author":"Chen","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.cis.2026.104054_bb1375","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41565-025-01857-9","article-title":"Tandem-controlled lysosomal assembly of nanofibres induces pyroptosis for cancer immunotherapy","volume":"20","author":"Zhang","year":"2025","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb1380","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1016\/j.apsb.2022.03.010","article-title":"Dual-responsive nanoparticles with transformable shape and reversible charge for amplified chemo-photodynamic therapy of breast cancer","volume":"12","author":"Jia","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.cis.2026.104054_bb1385","author":"FDA"},{"key":"10.1016\/j.cis.2026.104054_bb1390","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1038\/s41467-025-63726-2","article-title":"Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo","volume":"16","author":"Voke","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.104054_bb1395","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","article-title":"Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery","volume":"15","author":"Zelepukin","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.104054_bb1400","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114238","article-title":"Why nanoparticles prefer liver macrophage cell uptake in vivo","volume":"185","author":"Ngo","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2026.104054_bb1405","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12951-021-01203-w","article-title":"Acute exposure to gold nanoparticles aggravates lipopolysaccharide-induced liver injury by amplifying apoptosis via ROS-mediated macrophage-hepatocyte crosstalk","volume":"20","author":"Yang","year":"2022","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb1410","doi-asserted-by":"crossref","first-page":"9141","DOI":"10.1039\/C8NR00554K","article-title":"Mesoporous silica nanoparticles induced hepatotoxicity via NLRP3 inflammasome activation and caspase-1-dependent pyroptosis","volume":"10","author":"Zhang","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.cis.2026.104054_bb1415","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/acsnanomed.5c00083","article-title":"Adaptive ROS regulating nanomedicine for tumor catalytic and immunotherapy beyond oxidative overload","volume":"1","author":"Zhu","year":"2026","journal-title":"ACS Nano Med"},{"key":"10.1016\/j.cis.2026.104054_bb1420","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202106049","article-title":"Cytotoxicity of metal-based nanoparticles: from mechanisms and methods of evaluation to pathological manifestations","volume":"9","author":"Xiong","year":"2022","journal-title":"Adv Sci"},{"key":"10.1016\/j.cis.2026.104054_bb1425","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13045-026-01780-z","article-title":"The distinct roles of ROS in tumor immunity: from mechanisms to immunotherapeutic applications","volume":"19","author":"Li","year":"2026","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.cis.2026.104054_bb1430","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s00204-018-2223-y","article-title":"Revisiting the stress paradigm for silica nanoparticles: decoupling of the anti-oxidative defense, pro-inflammatory response and cytotoxicity","volume":"92","author":"Fritsch-Decker","year":"2018","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.cis.2026.104054_bb1435","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1021\/acs.chemrestox.9b00478","article-title":"Functionalized surface-charged SiO2 nanoparticles induce pro-inflammatory responses, but are not lethal to Caco-2 cells","volume":"33","author":"Tada-Oikawa","year":"2020","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.cis.2026.104054_bb1440","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111611","article-title":"Regulation of ferroptosis ameliorates silica nanoparticle-induced lung injury by inhibiting NCOA4-mediated ferritinophagy","volume":"418","author":"Guo","year":"2025","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.cis.2026.104054_bb1445","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.1114397","article-title":"Toxic potential of materials at the nanolevel","volume":"311","author":"Nel","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.cis.2026.104054_bb1450","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12011-023-03683-3","article-title":"Zinc oxide nanoparticles induce renal injury by initiating oxidative stress, mitochondrial damage and apoptosis in renal tubular epithelial cells","volume":"202","author":"Liu","year":"2024","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.cis.2026.104054_bb1455","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.2147\/IJN.S378727","article-title":"Respiratory exposure to copper oxide particles causes multiple organ injuries via oxidative stress in a rat model","volume":"17","author":"Wang","year":"2022","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2026.104054_bb1460","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70107","article-title":"Reactive oxygen species (ROS) and their profound influence on regulating diverse aspects of cancer: a concise review","volume":"86","author":"Tiwari","year":"2025","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.cis.2026.104054_bb1465","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/942916","article-title":"Mechanisms of nanoparticle-induced oxidative stress and toxicity","volume":"2013","author":"Manke","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.cis.2026.104054_bb1470","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.2147\/IJN.S209458","article-title":"Repeated intravenous administration of silica nanoparticles induces pulmonary inflammation and collagen accumulation via JAK2\/STAT3 and TGF-\u03b2\/Smad3 pathways in vivo","volume":"14","author":"Yu","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2026.104054_bb1475","doi-asserted-by":"crossref","DOI":"10.1016\/j.impact.2024.100494","article-title":"Protein corona exacerbated inflammatory response in macrophages elicited by CdTe quantum dots","volume":"33","author":"Liu","year":"2024","journal-title":"NanoImpact"},{"key":"10.1016\/j.cis.2026.104054_bb1480","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2026.104054_bb1485","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1188864","article-title":"What are NLRP3-ASC specks? An experimental progress of 22 years of inflammasome research","volume":"14","author":"Nagar","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.cis.2026.104054_bb1490","doi-asserted-by":"crossref","first-page":"19449","DOI":"10.1073\/pnas.1008155107","article-title":"Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1\u03b1 and IL-1\u03b2","volume":"107","author":"Yazdi","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cis.2026.104054_bb1495","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.2147\/JIR.S371536","article-title":"Characterization of cathepsin B in mediating silica nanoparticle-induced macrophage pyroptosis via an NLRP3-dependent manner","volume":"15","author":"Ma","year":"2022","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.cis.2026.104054_bb1500","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1039\/D2NA00534D","article-title":"The toxicity of nanoparticles and their interaction with cells: an in vitro metabolomic perspective","volume":"5","author":"Awashra","year":"2023","journal-title":"Nanoscale Adv"},{"key":"10.1016\/j.cis.2026.104054_bb1505","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/ar600012y","article-title":"Nanoparticle interaction with biological membranes: does nanotechnology present a janus face?","volume":"40","author":"Leroueil","year":"2007","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.cis.2026.104054_bb1510","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2022.925399","article-title":"Cationic carbon nanoparticles induce inflammasome-dependent pyroptosis in macrophages via lysosomal dysfunction","volume":"4","author":"Arezki","year":"2022","journal-title":"Front Toxicol"},{"key":"10.1016\/j.cis.2026.104054_bb1515","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.3390\/pharmaceutics14122657","article-title":"Mitochondrial dysfunction: pathophysiology and mitochondria-targeted drug delivery approaches","volume":"14","author":"Khan","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cis.2026.104054_bb1520","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1038\/s41598-019-40579-6","article-title":"Cationic gold nanoparticles elicit mitochondrial dysfunction: a multi-omics study","volume":"9","author":"Gallud","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.cis.2026.104054_bb1525","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1039\/C7TB03153J","article-title":"Induction of oxidative stress and sensitization of cancer cells to paclitaxel by gold nanoparticles with different charge densities and hydrophobicities","volume":"6","author":"Sun","year":"2018","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.cis.2026.104054_bb1530","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.2147\/IJN.S364381","article-title":"Role of surface charge of nanoscale ultrasound contrast agents in complement activation and phagocytosis","volume":"17","author":"Zhou","year":"2022","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2026.104054_bb1535","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.apsb.2017.11.009","article-title":"Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment","volume":"8","author":"Li","year":"2018","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.cis.2026.104054_bb1540","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.cis.2026.104054_bb1545","doi-asserted-by":"crossref","DOI":"10.1002\/bmm2.70074","article-title":"Mimic, target, and adapt: cell membrane-coated nanoplatforms for precision and immune-guided cancer treatment","author":"Alam","year":"2026","journal-title":"BMEMat"},{"key":"10.1016\/j.cis.2026.104054_bb1550","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1021\/acsnano.2c09033","article-title":"Tumor\u2013antigen activated dendritic cell membrane-coated biomimetic nanoparticles with orchestrating immune responses promote therapeutic efficacy against glioma","volume":"17","author":"Ma","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2026.104054_bb1555","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1038\/s41467-023-40280-3","article-title":"Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment","volume":"14","author":"Zou","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.104054_bb1560","article-title":"Genetically engineered membrane-coated nanoparticles for enhanced prostate-specific membrane antigen targeting and ferroptosis treatment of castration-resistant prostate cancer","volume":"11","author":"Li","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.cis.2026.104054_bb1565","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117248","article-title":"Current knowledge of hybrid nanoplatforms composed of exosomes and organic\/inorganic nanoparticles for disease treatment and cell\/tissue imaging","volume":"178","author":"Soltanmohammadi","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cis.2026.104054_bb1570","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1038\/s41467-019-11718-4","article-title":"Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy","volume":"10","author":"Yong","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.104054_bb1575","doi-asserted-by":"crossref","first-page":"8882","DOI":"10.1021\/acsnano.4c16629","article-title":"Exosome-inspired lipid nanoparticles for enhanced tissue penetration","volume":"19","author":"Bang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2026.104054_bb1580","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12951-021-01221-8","article-title":"Charge reversal nano-systems for tumor therapy","volume":"20","author":"Zhang","year":"2022","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb1585","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202304713","article-title":"Charge-reversible nanoparticles: advanced delivery systems for therapy and diagnosis","volume":"20","author":"Veider","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.cis.2026.104054_bb1590","doi-asserted-by":"crossref","first-page":"302","DOI":"10.7150\/thno.13686","article-title":"Active tumor permeation and uptake of surface charge-switchable theranostic nanoparticles for imaging-guided photothermal\/chemo combinatorial therapy","volume":"6","author":"Hung","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.cis.2026.104054_bb1595","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jconrel.2021.09.005","article-title":"Charge-reversal biodegradable MSNs for tumor synergetic chemo\/photothermal and visualized therapy","volume":"338","author":"Li","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb1600","article-title":"Dual enzyme-responsive polymer-drug conjugates induce diverse cells mutual transcytosis to achieve deep pancreatic tumor penetration","volume":"64","author":"Sun","year":"2025","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.cis.2026.104054_bb1605","article-title":"Chiral Gd-DOTA-functionalized polymer nanoprobe with GGT-triggered charge reversal for tumor-specific MRI\/fluorescence imaging","volume":"15","author":"Zhang","year":"2026","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.cis.2026.104054_bb1610","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1021\/acsami.3c11500","article-title":"Enzyme-responsive modular peptides enhance tumor penetration of quantum dots via charge reversal strategy","volume":"16","author":"Dai","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.cis.2026.104054_bb1615","article-title":"New approaches of green silver nanoparticles for cancer and biomedical applications: a review","volume":"6","author":"Kumari","year":"2025","journal-title":"Explor Target Anti-tum Ther"},{"key":"10.1016\/j.cis.2026.104054_bb1620","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fnano.2024.1490980","article-title":"Plant-mediated gold nanoparticles in cancer therapy: exploring anti-cancer mechanisms, drug delivery applications, and future prospects","volume":"6","author":"Nisha","year":"2024","journal-title":"Front Nanotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb1625","doi-asserted-by":"crossref","DOI":"10.3389\/fnano.2021.801620","article-title":"Role of biogenic capping agents in the synthesis of metallic nanoparticles and evaluation of their therapeutic potential","volume":"3","author":"Sidhu","year":"2022","journal-title":"Front Nanotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb1630","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-08468-3","article-title":"Green synthesis of silver nanoparticles using Magnolia alba leaf extracts and evaluating their antimicrobial, anticancer, antioxidant, and photocatalytic properties","volume":"15","author":"De Mel","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.cis.2026.104054_bb1635","doi-asserted-by":"crossref","first-page":"47539","DOI":"10.1007\/s11356-022-19166-2","article-title":"Potential of green-synthesized selenium nanoparticles using apigenin in human breast cancer MCF-7 cells","volume":"29","author":"Al-Otaibi","year":"2022","journal-title":"Environ Sci Pollut Res"},{"key":"10.1016\/j.cis.2026.104054_bb1640","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3390\/polym15102393","article-title":"Copolymer-green-synthesized copper oxide nanoparticles enhance folate-targeting in cervical cancer cells in vitro","volume":"15","author":"Jagaran","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.cis.2026.104054_bb1645","series-title":"Artificial Intelligence in Nanotechnology: Advanced Drug Delivery and Sustainable Biotechnology Solutions","first-page":"115","article-title":"Chapter 4. AI-driven nanocarrier design for smart drug delivery: bridging intelligence and precision in therapeutics","volume":"1525","author":"Uddin","year":"2026"},{"key":"10.1016\/j.cis.2026.104054_bb1650","doi-asserted-by":"crossref","DOI":"10.1002\/bmm2.70004","article-title":"Artificial intelligence-assisted design, synthesis and analysis of smart biomaterials","volume":"3","author":"Jiang","year":"2025","journal-title":"BMEMat"},{"key":"10.1016\/j.cis.2026.104054_bb1655","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114573","article-title":"High-throughput, AI-assisted design and optimization of lipid nanoparticles for drug delivery","volume":"391","author":"Zeng","year":"2026","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb1660","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2147\/IJN.S344208","article-title":"Predicting nanoparticle delivery to tumors using machine learning and artificial intelligence approaches","volume":"17","author":"Lin","year":"2022","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2026.104054_bb1665","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2024.08.015","article-title":"Predicting tissue distribution and tumor delivery of nanoparticles in mice using machine learning models","volume":"374","author":"Mi","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb1670","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012560","article-title":"Physiologically based pharmacokinetic modeling of nanoparticle biodistribution: a review of existing models, simulation software, and data analysis tools","volume":"23","author":"Kutumova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2026.104054_bb1675","first-page":"409","article-title":"Streamlining physiologically-based pharmacokinetic model design for intravenous delivery of nanoparticle drugs","volume":"11","author":"Le","year":"2022","journal-title":"CPT: Pharmacometr Syst Pharmacol"},{"key":"10.1016\/j.cis.2026.104054_bb1680","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2023.07.040","article-title":"An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice","volume":"361","author":"Chou","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.104054_bb1685","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1039\/D3BM00741C","article-title":"A machine learning approach to predict cellular uptake of pBAE polyplexes","volume":"11","author":"Loecher","year":"2023","journal-title":"Biomater Sci"},{"key":"10.1016\/j.cis.2026.104054_bb1690","first-page":"1280","article-title":"Machine learning-guided high throughput nanoparticle design","volume":"3","author":"Ortiz-Perez","year":"2024","journal-title":"Dig Dis"},{"key":"10.1016\/j.cis.2026.104054_bb1695","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41565-023-01323-4","article-title":"Machine-learning-assisted single-vessel analysis of nanoparticle permeability in tumour vasculatures","volume":"18","author":"Zhu","year":"2023","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb1700","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3389\/fphar.2017.00952","article-title":"Modulating the tumor microenvironment to enhance tumor nanomedicine delivery","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cis.2026.104054_bb1705","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S570411","article-title":"Nanomedicines reshape the tumor microenvironment: multidimensional strategies from modulating \u201cbarriers\u201d to metabolic intervention","volume":"21","author":"Zhao","year":"2026","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2026.104054_bb1710","doi-asserted-by":"crossref","DOI":"10.1002\/bmm2.70062","article-title":"Reprogramming tumor immune microenvironment by ultrasound-responsive nanoplatforms for enhanced cancer immunotherapy","author":"Zhao","year":"2026","journal-title":"BMEMat"},{"key":"10.1016\/j.cis.2026.104054_bb1715","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nnano.2012.45","article-title":"Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner","volume":"7","author":"Chauhan","year":"2012","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb1720","article-title":"Targeted anti-cancer therapy: co-delivery of VEGF siRNA and phenethyl isothiocyanate (PEITC) via cRGD-modified lipid nanoparticles for enhanced anti-angiogenic efficacy","volume":"19","author":"Li","year":"2024","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.cis.2026.104054_bb1725","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.trecan.2018.02.005","article-title":"Reengineering the physical microenvironment of tumors to improve drug delivery and efficacy: from mathematical modeling to bench to bedside","volume":"4","author":"Stylianopoulos","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.cis.2026.104054_bb1730","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1073\/pnas.1818357116","article-title":"Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma","volume":"116","author":"Zhao","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cis.2026.104054_bb1735","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.2147\/IJN.S257164","article-title":"Mechanism investigation of hyaluronidase-combined multistage nanoparticles for solid tumor penetration and antitumor effect","volume":"15","author":"Chen","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2026.104054_bb1740","first-page":"265","article-title":"Increased nanoparticle penetration in collagenase-treated multicellular spheroids","volume":"2","author":"Goodman","year":"2007","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2026.104054_bb1745","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1186\/s12951-025-03815-y","article-title":"Collagenase-mediated extracellular matrix targeting for enhanced drug penetration and therapeutic efficacy in nanoscale delivery systems for cancer therapy","volume":"23","author":"Gong","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.cis.2026.104054_bb1750","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","article-title":"Extracellular matrix and its therapeutic potential for cancer treatment","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.cis.2026.104054_bb1755","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13045-025-01688-0","article-title":"Cancer associated fibroblasts in cancer development and therapy","volume":"18","author":"Jia","year":"2025","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.cis.2026.104054_bb1760","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70788","article-title":"Fibrotic fortresses and therapeutic frontiers: pancreatic stellate cells and the extracellular matrix in pancreatic cancer","volume":"14","author":"Sigirli","year":"2025","journal-title":"Cancer Med"},{"key":"10.1016\/j.cis.2026.104054_bb1765","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.7150\/thno.36936","article-title":"TGF-\u03b2 inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity","volume":"10","author":"Panagi","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.cis.2026.104054_bb1770","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189109","article-title":"Augmentation of the EPR effect by mild hyperthermia to improve nanoparticle delivery to the tumor","volume":"1879","author":"Aloss","year":"2024","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.cis.2026.104054_bb1775","doi-asserted-by":"crossref","first-page":"9387","DOI":"10.2147\/CMAR.S225607","article-title":"Local tumor ischemia-reperfusion mediated by ultrasound-targeted microbubble destruction enhances the anti-tumor efficacy of doxorubicin chemotherapy","volume":"11","author":"Wu","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.cis.2026.104054_bb1780","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.ultrasmedbio.2019.07.683","article-title":"Effect of ultrasound on the vasculature and extravasation of nanoscale particles imaged in real time","volume":"45","author":"Yemane","year":"2019","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.cis.2026.104054_bb1785","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s11658-026-00974-0","article-title":"PRKN mediates the ubiquitination of SCAF8 to reduce the mRNA stability of KLF5 and its transcriptional activation of EFNA3 in colorectal cancer","volume":"31","author":"Song","year":"2026","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.cis.2026.104054_bb1790","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1021\/acs.jmedchem.3c01835","article-title":"Peptide\u2013drug conjugates: an emerging direction for the next generation of peptide therapeutics","volume":"67","author":"Dean","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.cis.2026.104054_bb1795","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3390\/bioengineering12050481","article-title":"Peptide\u2013drug conjugates as next-generation therapeutics: exploring the potential and clinical progress","volume":"12","author":"Jadhav","year":"2025","journal-title":"Bioengineering"},{"key":"10.1016\/j.cis.2026.104054_bb1800","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/ph12030114","article-title":"Lutathera\u00ae: the first FDA- and EMA-approved radiopharmaceutical for peptide receptor radionuclide therapy","volume":"12","author":"Hennrich","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cis.2026.104054_bb1805","doi-asserted-by":"crossref","unstructured":"Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, et al. Phase 3 trial of 177Lu-dotatate for midgut neuroendocrine tumors. N Engl J Med.376:125-135. Doi:10.1056\/NEJMoa1607427.","DOI":"10.1056\/NEJMoa1607427"},{"key":"10.1016\/j.cis.2026.104054_bb1810","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/ph15101292","article-title":"[177Lu]Lu-PSMA-617 (PluvictoTM): the first Fda-approved radiotherapeutical for treatment of prostate cancer","volume":"15","author":"Hennrich","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cis.2026.104054_bb1815","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2967\/jnumed.114.147413","article-title":"Preclinical evaluation of a tailor-made DOTA-conjugated PSMA inhibitor with optimized linker moiety for imaging and endoradiotherapy of prostate cancer","volume":"56","author":"Bene\u0161ov\u00e1","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cis.2026.104054_bb1820","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/ph15010013","article-title":"Expanding theranostic radiopharmaceuticals for tumor diagnosis and therapy","volume":"15","author":"Barca","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cis.2026.104054_bb1825","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101374","article-title":"The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDA","volume":"18","author":"Olivier","year":"2022","journal-title":"Transl Oncol"},{"key":"10.1016\/j.cis.2026.104054_bb1830","doi-asserted-by":"crossref","first-page":"8696","DOI":"10.1038\/s41467-025-63718-2","article-title":"Engineered exosomes with KrasG12D specific siRNA in pancreatic cancer: a phase I study with immunological correlates","volume":"16","author":"Kalluri","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2026.104054_bb1835","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1016\/j.apsb.2022.02.023","article-title":"Cell membrane coated-nanoparticles for cancer immunotherapy","volume":"12","author":"Zeng","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.cis.2026.104054_bb1840","article-title":"Improving tumor treatment: Cell membrane-coated nanoparticles for targeted therapies","volume":"32","author":"Grav\u00e1n","year":"2025","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.cis.2026.104054_bb1845","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S2468-1253(22)00167-4","article-title":"Dual &#x3b1;V-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 study","volume":"7","author":"Dean","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cis.2026.104054_bb1850","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1200\/JCO.2025.43.4_suppl.728","article-title":"AGITG ASCEND: randomised, double-blind phase II study of certepetide or placebo added to gemcitabine plus nab-paclitaxel in patients with untreated metastatic pancreatic ductal adenocarcinoma: initial results","volume":"43","author":"Dean","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cis.2026.104054_bb1855","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.PANCREATIC25-A070","article-title":"Abstract A070: CENDIFOX: phase I\/II trial of CEND-1 (LSTA1, certepetide) with neoadjuvant mFOLFIRINOX in resectable and borderline resectable PDAC","volume":"85","author":"Kasi","year":"2025","journal-title":"Cancer Res"},{"key":"10.1016\/j.cis.2026.104054_bb1860","doi-asserted-by":"crossref","unstructured":"Dean AP, Johansson M, Yusoff I, Rao S, Sparrow S, Kumarasinghe P, et al. Immunotherapy engagement in pancreatic adenocarcinoma: provisional results of iLSTA study\u2014 Durvalumab, LSTA1 (certepetide), gemcitabine, and nab-paclitaxel for locally advanced pancreatic ductal adenocarcinoma. J Clin Oncol 2025;43:746-. Doi:https:\/\/doi.org\/10.1200\/JCO.2025.43.4_suppl.746.","DOI":"10.1200\/JCO.2025.43.4_suppl.746"},{"key":"10.1016\/j.cis.2026.104054_bb1865","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1111\/cas.15086","article-title":"TH1902, a new docetaxel-peptide conjugate for the treatment of sortilin-positive triple-negative breast cancer","volume":"112","author":"Demeule","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cis.2026.104054_bb1870","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1200\/JCO.2024.42.16_suppl.3081","article-title":"Long-term efficacy, safety and PK data of TH1902 (sudocetaxel zendusortide) in solid tumors: a novel SORT1-targeting peptide-drug-conjugate (PDC)","volume":"42","author":"Winer","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cis.2026.104054_bb1875","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.16_suppl.e15113","article-title":"Efficacy and safety data from Ph1b, dose optimization trial of two doses of TH1902 (sudocetaxel zendusortide), a novel SORT1-targeting peptide drug conjugate (PDC), administered weekly vs q3weekly in patients (pts) with advanced ovarian cancer","volume":"43","author":"Winer","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cis.2026.104054_bb1880","doi-asserted-by":"crossref","first-page":"14337","DOI":"10.1021\/acs.jmedchem.2c00065","article-title":"Discovery of BT8009: a nectin-4 targeting bicycle toxin conjugate for the treatment of cancer","volume":"65","author":"Mudd","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.cis.2026.104054_bb1885","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1158\/1535-7163.MCT-21-0875","article-title":"BT8009; a nectin-4 targeting bicycle toxin conjugate for treatment of solid tumors","volume":"21","author":"Rigby","year":"2022","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.cis.2026.104054_bb1890","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1200\/JCO-25-00559","article-title":"First-in-human, phase I\/II dose escalation and expansion study of zelenectide pevedotin in patients with advanced solid tumors: results from monotherapy dose escalation","volume":"43","author":"Baldini","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cis.2026.104054_bb1895","doi-asserted-by":"crossref","first-page":"12281","DOI":"10.1021\/acsnano.9b09713","article-title":"What went wrong with anticancer nanomedicine design and how to make it right","volume":"14","author":"Sun","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.cis.2026.104054_bb1900","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature08956","article-title":"Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles","volume":"464","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cis.2026.104054_bb1905","doi-asserted-by":"crossref","first-page":"11449","DOI":"10.1073\/pnas.1411393111","article-title":"Correlating animal and human phase Ia\/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA","volume":"111","author":"Zuckerman","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cis.2026.104054_bb1910","doi-asserted-by":"crossref","unstructured":"Klinz S, Eckelhofer I, Gaddy D, Geretti E, Hendriks B, Lee H, et al. Abstract 3637: MM-302, a HER2-targeted liposomal doxorubicin, shows binding\/uptake and efficacy in HER2 2+ cells and xenograft models. Cancer Res 2011;71:3637-. Doi:https:\/\/doi.org\/10.1158\/1538-7445.AM2011-3637.","DOI":"10.1158\/1538-7445.AM2011-3637"},{"key":"10.1016\/j.cis.2026.104054_bb1915","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1158\/0008-5472.CAN-15-1518","article-title":"Dual HER2 targeting with trastuzumab and liposomal-encapsulated doxorubicin (MM-302) demonstrates synergistic antitumor activity in breast and gastric cancer","volume":"76","author":"Espelin","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.cis.2026.104054_bb1920","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1158\/1078-0432.CCR-16-3193","article-title":"64Cu-MM-302 positron emission tomography quantifies variability of enhanced permeability and retention of nanoparticles in relation to treatment response in patients with metastatic breast cancer","volume":"23","author":"Lee","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cis.2026.104054_bb1925","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41416-018-0235-2","article-title":"Safety and pharmacokinetics of MM-302, a HER2-targeted antibody\u2013liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study","volume":"119","author":"Munster","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cis.2026.104054_bb1930","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12885-016-2385-z","article-title":"HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician\u2019s choice plus trastuzumab in patients with previously treated, anthracycline-na\u00efve, HER2-positive, locally advanced\/metastatic breast cancer","volume":"16","author":"Miller","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cis.2026.104054_bb1935","author":"Trials"},{"key":"10.1016\/j.cis.2026.104054_bb1940","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003651","article-title":"Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile","volume":"4","author":"Hrkach","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cis.2026.104054_bb1945","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/cmdc.201200052","article-title":"Docetaxel nanotechnology in anticancer therapy","volume":"7","author":"Zhao","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.cis.2026.104054_bb1950","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1158\/1078-0432.CCR-15-2548","article-title":"Phase I study of PSMA-targeted docetaxel-containing nanoparticle BIND-014 in patients with advanced solid tumors","volume":"22","author":"Von Hoff","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cis.2026.104054_bb1955","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jamaoncol.2018.2168","article-title":"Safety and efficacy of BIND-014, a docetaxel nanoparticle targeting prostate-specific membrane antigen for patients with metastatic castration-resistant prostate cancer: a phase 2 clinical trial","volume":"4","author":"Autio","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cis.2026.104054_bb1960","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/533304a","article-title":"Bankruptcy filing worries developers of nanoparticle cancer drugs","volume":"533","author":"Ledford","year":"2016","journal-title":"Nature"}],"container-title":["Advances in Colloid and Interface Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001868626002794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001868626002794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:23:12Z","timestamp":1790799792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001868626002794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":392,"alternative-id":["S0001868626002794"],"URL":"https:\/\/doi.org\/10.1016\/j.cis.2026.104054","relation":{},"ISSN":["0001-8686"],"issn-type":[{"value":"0001-8686","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding the uptake pathway of nanoparticles in tumor cells: mechanisms, developments and challenges","name":"articletitle","label":"Article Title"},{"value":"Advances in Colloid and Interface Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cis.2026.104054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104054"}}